How healthcare VC firms are thinking about longevity
Christina Farr
8 min read
7wire shared their thesis and market map with us that it created for its own LPs
Weekly News: The HIMs/Novo breakup, digital health reimbursements and new funding rounds
Christina Farr and Annalisa Merelli
7 min read
Drama between an online prescriber and the pharma company was the most interesting drama of the week
Why is the longevity sector taking off? With Lifeforce CEO Dugal Bain-Kim
In this episode of Second Opinion, Christina Farr and Lifeforce CEO Dugal Bain-Kim dive into the billion-dollar longevity economy, examining why health optimization became a status symbol and how personal data drives better health decisions than population-level advice.
AI taking healthcare jobs, and enrolling patients in Medicaid at a laundromat
Christina Farr
12 min read
Could the future of healthcare incorporate both more AI and more humanity?
Meeting people where they are: Healthcare in America's laundromats with Fabric's Courtney Bragg
This week on Second Opinion, Christina Far interviews Courtney Bragg, CEO and co-founder of Fabric Health, about their innovative approach to delivering healthcare services in laundromats.
Investors are all in on digital health, but are missing oral health care.
Christina Farr
12 min read
A comprehensive review of the oral healthcare space that includes a market map
Paid Pilots: A hard lesson about selling into Enterprise customers
Christina Farr and Ankit Jain
8 min read
Don't get stuck selling products that customers only "kinda want"
Are we all out of a job? Examining AI’s impact in health with Towerbrook’s Eric Larsen
This week on Second Opinion podcast, Christina Farr and Ash Zenooz interview Eric Jon Larsen about the the potential and challenges of AI in healthcare and various industries, debating its role, accuracy, impact on jobs, and future implications for human society.
I got the health scan that 100,000 people are on the waitlist for
Christina Farr
15 min read
A few observations from Stockholm, where I got the Neko experience
From Hinge Health’s IPO to Regeneron buying 23andMe: Unpacking the mega deals of the week
This week on Second Opinion, Christina Farr and Luba Greenwood discuss the acquisition of 23andMe by Regeneron, the involvement of Hims and Hers in the GLP-1 market, and two significant IPOs in the digital health sector.
The biggest winners from the Hinge IPO - and what that says about digital health investing
Christina Farr and Rebecca Mitchell
8 min read
One tiny fund I hadn’t heard of absolutely crushed it
Why tech and medicine need each other with GC's Steve Klasko & THL Partners' Jessie Beegle
General Catalyst’s Steve Klasko and THL Partners’ Jessie Beegle join Christina Farr on why healthcare’s problems persist despite decades of technology — integrating AI, working around outdated systems, and aligning incentives so change actually sticks.